A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)
2023-04-05
عنوان الدراسة
A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)
داعم الدراسة
Sanofi
دواء الدراسة
Dupilumab
رقم بروتوكول الدراسة
EFC16724
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。